Vance Broach

Memorial Sloan Kettering Cancer Center

Papers

7

Total Citations

173

H-Index

6

About

Dr. Vance Broach is a leading gynecologic oncologist whose research is transforming the surgical management of gynecologic cancers, with a particular focus on minimally invasive and robotic-assisted techniques. His work critically evaluates the oncologic safety and perioperative benefits of these approaches compared to traditional open surgery. Dr. Broach’s landmark study, “Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer” (79 citations), has provided vital survival outcome data that directly informs clinical decision-making. He has further demonstrated the advantages of robotic surgery in vulnerable populations, such as the frail elderly, and has pioneered efforts to standardize opioid prescriptions after ambulatory oncologic surgery, significantly reducing overprescription (24 citations). His extensive comparative analyses across uterine cancers—including endometrioid adenocarcinoma, carcinosarcoma, and serous carcinoma—consistently show that robot-assisted and conventional laparoscopy do not compromise long-term oncologic outcomes. With a growing body of highly cited work, Dr. Broach is a key voice in advancing safer, more effective surgical care for women with cancer.

Research Focus

Key Achievements

6
H-Index
7
Papers
173
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes
79 citations · 2020
📈 Most Prolific Year: 2020 (4 Papers)
🤝 Key Collaborators: 38
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago